Fig. 3From: Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axisPART1 targets miR-503-5p. A The predicted complementary binding site of PART1 and miR-503-5p. B The luciferase activity in OC cells co-transfected with pGL3-PART1 WT/pGL3-PART1 MUT and miR-503-5p/miR-NC was determined by dual luciferase reporter assay. ***Pâ<â0.001 vs. the miR-NC group. C The expression of miR-503-5p in OC tissues (nâ=â50) and normal tissues (nâ=â50) was detected by qRT-PCR. ***Pâ<â0.001 vs. the normal group. D The correlation between the expression PART1 and miR-503-5p in OC tissues was assessed by Pearsonâs correlation analysis. Pâ<â0.001, R2â=â0.665. E The expression of miR-503-5p after transfection of sh-PART1â2/NC into OC cells was detected by qRT-PCR. ***Pâ<â0.001 vs. the sh-NC groupBack to article page